Megafine Pharma (P) Limited
CEP Certificates (EDQM COS List)
Megafine Pharma (P) Limited
CEP Database
Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.
- Total Records 11
- Latest End Date -
- Data Source EDQM
- Last Updated 2025-05-30
Company Overview
Social Profiles
Company Snapshot
Megafine Pharma (P) Limited
Sethna 4th floor, 55 Maharshi Karve Road, Marine Lines, Mumbai – 400 002 Maharashtra
India
megafine.in/ info@megafine.in View on MapCEP Records Timeline (11 records)
Product
Quetiapine Fumarate
Substance
MEGA FINE PHARMA PRIVATE LIMITED Mumbai IN
Certificate No.
CEP 2014-198 - Rev 02
Substance No.
2541
Issue Date
2025-05-30
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2014-198 - Rev 02
Substance No.: 2541
Product
Solifenacin succinate, Improved Process
Substance
MEGA FINE PHARMA PRIVATE LIMITED Mumbai IN
Certificate No.
CEP 2024-463 - Rev 00
Substance No.
2779
Issue Date
2025-01-02
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2024-463 - Rev 00
Substance No.: 2779
Product
Rivaroxaban, Micronised, improved Process
Substance
MEGA FINE PHARMA PRIVATE LIMITED Mumbai IN
Certificate No.
CEP 2024-353 - Rev 00
Substance No.
2932
Issue Date
2024-12-12
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2024-353 - Rev 00
Substance No.: 2932
Product
Teriflunomide
Substance
MEGA FINE PHARMA PRIVATE LIMITED Mumbai IN
Certificate No.
CEP 2022-418 - Rev 00
Substance No.
3036
Issue Date
2024-09-02
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2022-418 - Rev 00
Substance No.: 3036
Product
Donepezil hydrochloride, Monohydrate
Substance
MEGA FINE PHARMA PRIVATE LIMITED Mumbai IN
Certificate No.
CEP 2021-494 - Rev 00
Substance No.
2582
Issue Date
2024-02-22
End Date
-
Country
India
Identifiers
Certificate No.: CEP 2021-494 - Rev 00
Substance No.: 2582
Product
Rivaroxaban
Substance
MEGAFINE PHARMA (P) LIMITED Mumbai IN
Certificate No.
R0-CEP 2021-277 - Rev 01
Substance No.
2932
Issue Date
2023-08-07
End Date
-
Country
India
Identifiers
Certificate No.: R0-CEP 2021-277 - Rev 01
Substance No.: 2932
Product
Pyrantel embonate
Substance
MEGAFINE PHARMA (P) LIMITED Mumbai IN
Certificate No.
R1-CEP 2006-162 - Rev 02
Substance No.
1680
Issue Date
2023-02-15
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2006-162 - Rev 02
Substance No.: 1680
Product
Mirtazapine, Hemihydrate
Substance
MEGAFINE PHARMA (P) LIMITED Mumbai IN
Certificate No.
R1-CEP 2008-214 - Rev 03
Substance No.
2338
Issue Date
2023-01-25
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2008-214 - Rev 03
Substance No.: 2338
Product
Venlafaxine hydrochloride
Substance
MEGAFINE PHARMA (P) LIMITED Mumbai IN
Certificate No.
R1-CEP 2009-023 - Rev 02
Substance No.
2119
Issue Date
2022-06-13
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2009-023 - Rev 02
Substance No.: 2119
Product
Solifenacin succinate
Substance
MEGAFINE PHARMA (P) LIMITED Mumbai IN
Certificate No.
R1-CEP 2016-149 - Rev 00
Substance No.
2779
Issue Date
2022-03-17
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2016-149 - Rev 00
Substance No.: 2779
Product
Ziprasidone hydrochloride monohydrate
Substance
MEGAFINE PHARMA (P) LIMITED Mumbai IN
Certificate No.
R1-CEP 2011-141 - Rev 00
Substance No.
2421
Issue Date
2018-02-09
End Date
-
Country
India
Identifiers
Certificate No.: R1-CEP 2011-141 - Rev 00
Substance No.: 2421
Status Breakdown
11 total- Valid
Official Source
All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).
Visit EDQMRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Country
India
Identifiers
Certificate No.: CEP 2014-198 - Rev 02
Substance No.: 2541
100% Official Data
Directly from the EDQM CEP database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.